Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart wheelchair cushion aims to stop pressure sores

NCT ID NCT05403606

Prevention Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special seat cushion (GASPARD®) that measures pressure and sends alerts to a smartphone to help prevent pressure sores in people with spinal cord injuries. The trial included 134 participants who used manual wheelchairs. Unfortunately, the study was terminated early, so we have limited data on how well it worked.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
GASPARD® connected seat pressure measurement device
What this could lead to
If successful, this device could help prevent painful pressure sores in people with spinal cord injuries, improving quality of life and reducing medical costs.
What could go wrong
The trial was terminated early, so results are limited. The device may not be effective for everyone, and long-term benefits remain unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

134 people

The number who actually took part.

Started

Jan 2023

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients of both sexes with acquired spinal cord injury Traumatic or non-traumatic origin of the spinal cord injury * Motor level \< C6 * Complete or incomplete injury (AIS A, B and C impairment scale) * Primarily using a manual wheelchair (with or without electric propulsion assistance) as a means of mobility * At least 18 years of age * At any time after the occurrence of the spinal cord injury * Patients discharged from the center, with a first post-injury rehabilitation completed * Having participated in a specific therapeutic patient education on pressure ulcer prevention * No pelvic pressure sores under medical or surgical treatment at the time of inclusion * No aorto-iliac arterial disease that may promote pelvic ischemia (arterial Doppler \<6 months) * Patient using a cushion approved by the HAS * Patients with a smartphone Exclusion Criteria: * Congenital spinal cord injury * Motor level of the lesion \> or = C6 * Incomplete motor lesion (AIS D and E) * Patients who walk as their primary mode of ambulation * Use of an electric wheelchair * Minors

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

spinal cord injury decubitus ulcer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spinal cord injury

Contacts and locations

Locations

  • Le FORT Marc

    Nantes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.